Product category:
Clinical chemistry analysis
News Release from: Don Whitley Scientific | Subject: Macs VA500
Edited by the Laboratorytalk Editorial
Team on 01 November 2007
Control of hypoxic conditions in cancer
research
Macs specialised hypoxic environment allows accurate replication of biochemical pathways, critically important for biological and therapeutic understanding in the identification of new drug targets
Don Whitley Scientific's Modified Atmosphere Controlled System (Macs) VA500 is being used by the University of Bradford's Institute of Cancer Therapeutics (Bradford, UK) to identify and evaluate potential therapeutic compounds for treatment of hypoxic cells in tumours The hypoxic (low oxygen tension) tumour environment contains cells with particular characteristics whose main function is survival rather than reproduction
This article was originally published on Laboratorytalk on 27 Sep 2001 at 8.00am (UK)
Related stories
Microbial water quality monitoring
The Colifast Analyser is an automated early warning system for monitoring the microbial quality of water promising increased detection rate, high sensitivity, and rapid results
De-bugging the air
The Bacticlean upper air irradiation system from Don Whitley Scientific provides a highly efffective means of destroying airborne viruses and bacteria - including anthrax
Roger Phillips's research employs cellular assays to investigate changes over a closely controlled range of oxygen tensions in response to treatment with pharmaceutical compounds designed to act selectively on hypoxic cells.
Results from this laboratory have already led to two drugs entering clinical trials.
Essential to this research is the tight level of control over the gas mixture allowed by the user-friendly Macs variable atmosphere system.
With carbon dioxide required to maintain culture conditions as well as low oxygen tension, the workstation also functions as a carbon dioxide incubator to maintain hypoxic conditions for longer periods.
This is particularly important to ensure truly representative physiological conditions, rather than returning cells to their normal environment following treatment.
Cells can be retained under hypoxic conditions during drug exposure and afterwards, allowing longer-term effects to be observed.
Targeting these cells using conventional therapies has proved problematic, as they are very resistant to anti-cancer drugs and radiotherapy. Request a free brochure from Don Whitley Scientific ...
• Don Whitley Scientific: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
